Senior insider sale
Chief Medical Officer at XENON PHARMACEUTICALS INC. — senior position signals high conviction
$437.7K
7.07K shares
What this filing means
KENNEY CHRISTOPHER JOHN plans to sell 7.07K shares of XENON PHARMACEUTICALS INC. valued at approximately $437.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/28/2026ACC: 0001950047-26-008816
Officer· Chief Medical Officer
Since Aug 2021
7.07K
Shares to sell
$437.7K
Approx. market value
7.07K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted and Performance Stock Units
N/A
3/9/2026
7.07KTotal acquired7.07K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/9/2026 | Restricted and Performance Stock Units N/A | 7.07K | — |
| Total | 7.07K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
7.07K
Market value
$437.7K
8/28/2026
Total
Units
7.07K
Value
$437.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/28/2026 | 7.07K | $437.7K | NASDAQ | Planned |
| Total | 7.07K | $437.7K | ||